Results 141 to 150 of about 42,703 (308)

Utility of disease modifying antirheumatic drugs in "sawtooth" strategy. A prospective study of early rheumatoid arthritis patients up to 15 years [PDF]

, 1999
Tuulikki Sokka, Pekka Hannonen
openalex   +1 more source

Malignancies and immunoglobulin G4‐related disease

Rheumatology &Autoimmunity, EarlyView.
Immunoglobulin G4‐related disease (IgG4‐RD) is associated with increased cancer risk. Malignancies affect both IgG4‐RD involved organs, such as the lung, pancreas, bile duct, and prostate, and noninvolved organs, such as the gastrointestinal duct. B‐cell neoplasms constitute a proportion of the malignancies linked to this disease.
Jingna Li, Wen Zhang
wiley   +1 more source

Patients' knowledge of their antirheumatic drugs [PDF]

Arthritis & Rheumatism, 1986
Floyd H. Taylor, Murray Friedberg, John J. Nicholas, Wallace C. Christy   +3 more
openaire   +3 more sources

Effects of psoriatic arthritis‐targeted drugs on bone remodeling: Clinical evidence and molecular pathways

Rheumatology &Autoimmunity, EarlyView.
Mechanisms and therapeutic targets in psoriatic arthritis: balancing inflammatory bone resorption and bone formation. Abstract Psoriatic arthritis (PsA) is a chronic inflammatory disease characterized by diverse clinical manifestations. Of particular concern, osteopenia and osteoporosis are prevalent in 45.27% and 12.94% of PsA patients, respectively ...
Yingchao Sun, Cheng Xu, Mingli Ouyang, Yongmei Han   +3 more
wiley   +1 more source

The use of topical diclofenac in the pain management of osteoarthritis of the knee [PDF]

, 2006
Osteoarthritis (OA) is a common complaint that affects millions of people worldwide. As there is no cure for OA, drug treatment is the main form of management.
Banning, M
core  

Western and Chinese Antirheumatic Drug-Induced T Cell Apoptotic DNA Damage Uses Different Caspase Cascades and Is Independent of Fas/Fas Ligand Interaction [PDF]

, 2001
Jenn‐Haung Lai, Ling‐Jun Ho, Kuo-Cheng Lu, Deh‐Ming Chang, Men‐Fang Shaio, Shou‐Hwa Han   +5 more
openalex   +1 more source

Mannose Oligosaccharide‐Conjugated In Situ Pore‐Forming Injectable Hydrogels for Rheumatoid Arthritis Treatment by Reprogramming Macrophage Extracellular Vesicles

Small Methods, EarlyView.
Design of an injectable porous hydrogel modulating macrophages and their secreted EVs for joint defect repair in the pathology of rheumatoid arthritis. a) The solution containing HA and CS‐MOS, upon mixing with a crosslinker solution, undergoes porous hydrogel formation with the escape of generated CO₂ gas.
Anan Zhang, Yifan Ma, Yutong Liu, Shiyan Dong, Michelle Najarro Torres, Betty Y.S. Kim, Changsheng Liu, Lili Sun, Yuan Yuan, Wen Jiang   +9 more
wiley   +1 more source

Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin‐G4‐Related Digestive Disease

United European Gastroenterology Journal, EarlyView.
ABSTRACT Introduction United European Gastroenterology (UEG) Guidelines on immunoglobulin G4 (IgG4)‐related digestive disease provides evidence‐based recommendations for the diagnosis and management of IgG4‐related digestive disease. The aim of this study is to evaluate the adherence to recommendations of this IgG4 guideline across centers in Europe ...
Miroslav Vujasinovic, Marco Lanzillotta, Emma L. Culver, Vinciane Rebours, Joost P. H. Drenth, Milica Stojkovic Lalosevic, Jens Vikse, Natalya Gubergrits, Michael Hirth, Vincenzo Cardinale, Rodrigo Vieira Motta, Emanuel Della‐Torre, Nicole Sciberras, Marcello Maida, Artemis Trikola, Frank Lammert, Clemence Descourvières, Cyriel Ponsioen, Jens Brøndum Frøkjær, Alexander Schneider, Domenico Alvaro, Gabriele Capurso, J.‐Matthias Löhr   +22 more
wiley   +1 more source

Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis [PDF]

, 2003
D Aletaha
openalex   +1 more source

Comparative Effectiveness and Safety of Adalimumab, Secukinumab, and Upadacitinib in Psoriatic Arthritis: A Prospective Cohort Study Based on PARWCH Cohort

The Journal of Dermatology, EarlyView.
ABSTRACT Psoriatic arthritis (PsA) is a chronic inflammatory disease, with prevalence among psoriasis patients ranging from 6% to 42% across populations. Although targeted therapies such as adalimumab (ADA), secukinumab (SEC), and upadacitinib (UPA) have demonstrated efficacy in randomized controlled trials, real‐world head‐to‐head comparisons remain ...
Yiyi Wang, Jingya Gao, Furong Li, Luyuan Li, Yue Xiao, Hongxiang Hu, Xiya Peng, Min Yang, Dan Hao, Wei Yan, Dengmei Xia, Wei Li   +11 more
wiley   +1 more source